Review
Version 1
Preserved in Portico This version is not peer-reviewed
Transforming Vaccine Development
Version 1
: Received: 7 June 2020 / Approved: 7 June 2020 / Online: 7 June 2020 (10:11:02 CEST)
How to cite: Black, S.; Bloom, D. E.; Kaslow, D. C.; Pecetta, S.; Rappuoli, R. Transforming Vaccine Development. Preprints 2020, 2020060078. https://doi.org/10.20944/preprints202006.0078.v1 Black, S.; Bloom, D. E.; Kaslow, D. C.; Pecetta, S.; Rappuoli, R. Transforming Vaccine Development. Preprints 2020, 2020060078. https://doi.org/10.20944/preprints202006.0078.v1
Abstract
The urgency to develop vaccines against Covid-19 is putting pressure on the long and expensive development timelines which are normally required for development of lifesaving vaccines. There is a unique opportunity to take advantage of new technologies, smart and flexible design of clinical trials, and evolving regulatory science to speed up vaccine development against Covid-19 and transform vaccine development altogether.
Keywords
COVID-19; vaccine; vaccine development; vaccine discovery; systems biology; machine learning; platform technologies; adjuvants; smart clinical trials; human genetics; regulatory convergence; real world evidence; vaccines safety
Subject
Biology and Life Sciences, Immunology and Microbiology
Copyright: This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Comments (0)
We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.
Leave a public commentSend a private comment to the author(s)
* All users must log in before leaving a comment